The present disclosure relates generally to respiratory care systems, and more particularly, to mechanical ventilation systems or respiratory care systems, i.e., ventilators or respirators. The disclosure has particular utility for supplying respiratory support for a human or animal patient whose breathing is compromised by disease and will be described in connection with such utility, but also may be utilized for treating patients suffering from sleep apnea or for use as a component of an anesthesia system.
The current Covid-19 pandemic has highlighted the need for mechanical ventilation systems for respiratory compromised patients. Respiratory treatment apparatus can function to supply a patient with a supply of clean breathable gas (usually air, with or without supplemental oxygen) at a therapeutic pressure or pressures, at appropriate times during the subject's breathing cycle. Therapeutic pressure assist may be implemented in a synchronized fashion with the patient's breathing so as to permit greater pressures during a patient's normal breathing inspiration cycle and lower pressures during expiration. Therapeutic pressure assist also may be implemented to override a patient's normal breathing inspiration cycle.
Respiratory care systems typically include a gas or air flow generator or source of compressed gas or air, an air filter, a nasal, oral or full face mask, an air delivery conduit connecting the flow generator to the mask, various sensors and a microprocessor-based controller. Optionally, in lieu of a mask, a tracheotomy tube may also serve as a patient interface. The flow generator may include a servo-controlled motor and an impeller that forms a blower. In some cases a brake for the blower motor may be implemented to more rapidly reduce the speed of the blower so as to overcome the inertia of the motor and impeller. The braking can permit the blower to more rapidly achieve a lower pressure condition in time for synchronization with the patient's expiration despite the inertia. In some cases the flow generator also may include a valve capable configured to discharge generated air to atmosphere as a means for altering the pressure delivered to the patient as an alternative to motor speed control. The sensors measure, amongst other things, motor speed, mass flow rate and outlet pressure, such as with a pressure transducer or the like. The apparatus optionally may include a humidifier and/or heater elements in the path of the air delivery circuit. The controller may include data storage capacity with or without integrated data retrieval and display functions.
Respiratory care systems may be used for the treatment of many conditions, for example respiratory insufficiency or failure due to lung, neuromuscular or musculoskeletal disease and diseases of respiratory control. They may also be used for conditions related to sleep disordered breathing (SDB) (including mild obstructive sleep apnea (OSA)), allergy induced upper airway obstruction or early viral infection of the upper airway.
The current Covid-19 pandemic has stretched the current supply of respiratory care systems. Hospitals have been forced to share respiratory care systems, i.e., ventilators between two patients. Hospitals also have resorted to adapting apparatus conventionally used for obstructive sleep apnea as a poor substitute for conventional ventilators.
Also, current ventilators are complex it expensive devices which require constant supervision and adjustment, and which are prone to a breakdown.
The present a disclosure provides a simple low cost ventilator which overcomes the aforesaid and other disadvantages of the current state of the art ventilators.
More particularly, the present disclosure provides a ventilator having a significant advantages over current ventilators in terms of cost, size reduction, weight reduction, power reduction, noise reduction and reliability. One key to the instant ventilator of the present disclosure is a unique air or gas flow valve having an air or gas reservoir or accumulator incorporated into the valve. Incorporating an air or gas reservoir or accumulator into the value simplifies the construction and cost of the system, while providing improved response time thereby providing better patient support. Conventional ventilators employ proportional solenoid valves (PSOL valves) or turbine-based designs, where the core flow/pressure regulating component is a high-cost, multi-part item (order $1,500-$2,000). Also, in practice, static friction on the guide posts of the plunger of conventional PSOL valves may impair sensitivity of the valve, which in turn may result in hysteresis effects. To overcome the above and other disadvantages of conventional ventilators, the instant disclosure employs a novel low cost air or gas valve which has an integral air or gas reservoir or accumulator incorporated into the valve and which valve essentially consists of five primary elements and essentially one moving part.
In one embodiment, respiratory ventilator system of the present disclosure comprises an inlet configured to be connected to a pressurized air or gas source; an outlet configured to be connected to a patient interface; a valve in-line between the inlet and the outlet; and a control unit configured to control the valve for controlling flow of pressurized air or gas from the source to the patient, wherein the valve includes an air or gas reservoir or accumulator incorporated into the valve body.
In one preferred embodiment the valve comprises a valve gate controlled by a linear drive mechanism, preferably a servomechanism, a mechanical screw drive or a voice coil drive.
The patient interface may be selected from the group consisting of a mask, an intubation tube and a tracheotomy cannula, and pressurized air or gas source may be selected from the group consisting of an air canister, a compressor, an air pump, and pressurized airline.
The present disclosure also provides a method for assisting breathing of a patient in need of same, comprising: providing a ventilation system as above described; connecting the ventilation system to a source of pressurized air and to a patient interface; initiating a flow of air or gas to the ventilator system to precharge the air or gas reservoir or accumulator and controlling the flow of gas through the ventilation system by opening and closing the valve.
In another embodiment of the disclosure, the ventilator system includes a heater and/or a humidifier for conditioning the air or gas.
The valve may be opened and closed in response to the patient's normal breathing cycle, or the valve may be opened and closed to introduce a flow of air or gas to override the patient's normal breathing cycle.
The patient may be a human animal; or a non-human animal.
Further features and advantages of the instant disclosure will be seen from the following description, taken in conjunction with the accompanying drawings, wherein like numerals depict like parts, and wherein:
In the following detailed description the terms “air” and “gas”, and the terms “respirator” and “ventilator”, respectively, are used interchangeably.
The present respiratory treatment apparatus of the present disclosure provides supplemental air or oxygen to a patient in intermittent time intervals, based either on the patient's natural tidal breathing cycle, or based on a programmed a breathing cycle.
Referring to
Central to the ventilator system 10 of the current disclosure is a gas or airflow control valve 28 having an integral gas or air reservoir or accumulator as will be described below.
Referring now to
A valve gate 48 described below with reference to
Referring in particular to
A preload force in the negative X direction is applied to the valve gate 48 assembly by a spring assembly 56.
A set screw 50 drives the valve gate 48 in the X direction, setting both a spring assembly preload force and the initial position of the valve gate 48 along the X axis.
A spring plunger 58 provides a preload to the valve gate 48 in the negative Z direction. The intent is to continually maintain a gas-tight seal between the valve gate 48 and valve housing slide surface 50.
A gasket 60 maintains a gas-tight seal between the X-Z surfaces of the valve housing and the valve gate 48.
Referring again to
Expiratory flow valve 38 may be vented to atmosphere, or connected to scrub CO2 and recycle through gas input port 30. The system also include expiratory flow sensors or breathing sensors 40 for sensing the patient's breathing, and connections from the sensors for triggering the valve 28. The sensors may comprise air flow sensors, temperature sensors, sound sensors, CO2 sensors or motion or strain sensors for detecting movement of a patient's chest.
A valve cover 62 encloses the X-Z face of the valve housing, one on the positive Y axis and one on the negative Y axis. These covers create a gas-tight seal between the valve housing 40 and the atmosphere.
Referring again to
The valve flow resistance, RValve(δ) is calculated as follows:
Source flow, QSource(t), is governed by Equation 3 where:
Source flow rate, QSource(t)
Valve Depth along the Y axis, DValve
Valve Gate distance from valve housing sealing surface, δ
Gas Dynamic Viscosity, η (mass/(distance−time)
Source Flow Rate can then be determined by the following relationship:
Q
Source(t)=(PReservoir(t)−POutlet(t))/RValve(b) Equation 3)
The gas reservoir region in the valve housing is required, for while the average Source flow rate, QSource(t) does not exceed the available supply flow rate, QSupply(t), but the peak flow rate for QSource(t) does. This difference is made up from gas stored in the reservoir.
The force and moment balance for a generalized Valve Gate is illustrated in
(3FSpring+FPResistor)Cos θ=FPressureX+FActuator Equation 11)
F
Spring(L1+L2+L3)Cos θ2+FPResistor((2/3)H/COS θ)Cos θ2=FPressureXH/2+FActuatorZActuator Equation 12)
Referring also to
Gas flows through a flow rate sensor in line in the gas supply inlet 42 measuring source flow, QSource(t) that is a function of time, t. This flow measurement is utilized by the gas source controller & sensor/user interface to calculate the required ΔX command that controls QSource(t) as outlined by Equation 3.
As in the case of conventional ventilators, inlet gas or flow may require humidification and or heating. This is accomplished by commands from the controller to a humidification and heat module 72, which communicates with the reservoir 46, which adds water vapor, adding humidity to the gas flow, by either heating and subsequent evaporation of water, piezo atomization of water or other conventional methods of adding water to the gas flow. The gas can also be heated by this module as the gas flows through.
Gas flows through a relative humidity sensor measuring gas relative humidity, RH(t) that is a function of time, t. This measurement is utilized by the controller to generate the desired RH command, RHCommand(t) as a function of time.
A temperature and pressure source module measures gas temperature, T(t). This temperature measurement is utilized by the controller and sensor/user Interface to calculate the heating command, TCommand(t), to the Humidification and Heat Module to control gas temperature.
The temperature and pressure source module also may measure gas outlet pressure, POutlet(t). This pressure is utilized by the controller and sensor/user interface to calculate the required ΔX command that controls QSource(t) as outlined by Equation 3. The outlet of the temperature and pressure Module interfaces with a gas supply line that terminates with a pressurized nasal ventilator or other patient respiratory device such as a mask, cannula or intubation tube.
The gas source controller and sensor/user interface includes a sensor interface required for controlling the gas source flow rate, QSource(t), pressure, POutlet(t), temperature T(t) and relative humidity, RH(t). It generates the actuator command, ΔX(t), the temperature command TCommand(t) and the relative humidity command RHCommand(t). It also interfaces with the User Command Input Device & Status Monitor, receiving the user defined command set for gas source flow rate, QSource(t), pressure, POutlet(t), T(t) and RH(t). The gas source controller and sensor/user interface also provides sensor readings to the user command input device and status monitor.
The user command input device and status monitor allows the user to generate commands for gas source flow rate, QSource(t), pressure, POutlet(t), T(t) and RH(t). It also displays sensor readings. This device can be an I-Pad-like interface that communicates with the pressurized nasal ventilator assembly in a wired or wireless fashion.
The gas supply line can be a standard O2 line. The gas supply line also can be insulated in order to minimize gas heat loss when traveling from the gas source to the pressurized nasal ventilator assembly. The gas supply line also can incorporate an electrical heating element in order to maintain gas temperature, and also can incorporate a power and data wire set to provide power to the pressurized nasal ventilator assembly and receive sensor data from the pressurized nasal ventilator assembly. Since, the gas supply line has a know flow resistance, RGSL, the pressure at the point of entry to the pressurized nasal ventilator Gas Port, PSource(t) can be calculated as a result of knowing QSource(t), POutlet(t) and RGSL by the equation PSource(t)=POutlet(t)−QSource(t) RGSL.
Additional sensors can provide input for controlling the gas source assembly. These include but are not limited to air chamber pressure, PChamber(t), air chamber temperature, TAC, air chamber relative humidity, RHAC, ETCO2 and or O2 measurements sampled from the pressurized nasal ventilator assembly air chamber, impedance-based devices that monitor respiratory rate and tidal volume through chest cavity motion such as systems.
Referring to
The resulting ventilator system of the present disclosure is a low cost, relatively simple device, compared to conventional ventilation devices, that is robust, and conveniently small and light weight, and exceptionally fast in responding to patient needs.
This application is a continuation of U.S. patent application Ser. No. 18/023,288 filed Feb. 24, 2023, which is a national stage application of PCT/US2022/042531 filed Sep. 2, 2022, which claims benefit to U.S. Provisional Patent Application Ser. No. 63/240,298, filed Sep. 2, 2021, the contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
63240298 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 18023288 | Jan 0001 | US |
Child | 18128859 | US |